Results 221 to 230 of about 35,727 (251)

Chronic Kidney Disease-Mineral and Bone Disorder: “Renal Osteodystrophy”

2018
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is the current umbrella term used to describe a group of mineral and bone metabolism disorders secondary to chronic kidney disease (CKD). Bone abnormalities can be observed as early as CKD stage 2 (estimated GFR [eGFR] 60–89 mL/min/1.73 m2). Most patients with CKD stage 5 (eGFR
Janake Patel, Laura Amorese-O’Connell
openaire   +1 more source

Chronic Kidney Disease–Mineral and Bone Disorders

2021
Ignacio A. Portales-Castillo, Elaine W. Yu, Harald Jüppner, Sagar U. Nigwekar   +3 more
openaire   +1 more source

Effects of aging on chronic kidney disease mineral and bone disorder

Current Opinion in Nephrology & Hypertension
Purpose of review Aging and chronic kidney disease mineral and bone disorder (CKD-MBD) interact to worsen bone health, vascular calcification, and frailty in older patients. The altered FGF23–Klotho axis and disrupted mineral homeostasis emphasize the need for early interventions to mitigate fractures and cardiovascular ...
Washington A, Freire-Filho, Maria Aparecida, Dalboni, Rosilene M, Elias   +2 more
openaire   +2 more sources

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
Mitchell Rosner, Kenar D Jhaveri, Mark A Perazella   +2 more
exaly  

Epidemiology of chronic kidney disease: an update 2022

Kidney International Supplements, 2022
Csaba Kovesdy
exaly  

Chronic Kidney Disease Mineral and Bone Disorder

2009
Katherine Wesseling-Perry, Isidro B. Salusky   +1 more
openaire   +1 more source

Chronic Kidney Disease–Mineral and Bone Disorders

2020
Keith A. Hruska, Matthew J. Williams, Toshifumi Sugatani   +2 more
openaire   +1 more source

[Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].

Clinical calcium, 2009
Chronic kidney disease-mineral and bone disorder (CKD-MBD) progressively develops from predialysis period. Phosphorus retention, hypocalcemia, and disturbance in activation of vitamin D lead to CKD-MBD. It is important to control the metabolic disorder, so that PTH level can be reduced.
Daijo, Inaguma, Miho, Tatematsu
openaire   +1 more source

Dapagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2020
Bergur V Stefansson, Ricardo C Correa-Rotter, Glenn Chertow   +2 more
exaly  

Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation

Kidney International Supplements, 2011
Jordi Bover, Mario Cozzolino
exaly